TipRanks
Tryptamine Therapeutics Limited (AU:ENP)
ASX:ENP
Australian Market
ENP
Tryptamine Therapeutics
RESEARCH TOOLSreports
Want to see AU:ENP full AI Analyst Report?

Tryptamine Therapeutics (ENP) Ratios

19 Followers

Tryptamine Therapeutics Ratios

AU:ENP's free cash flow for Q4 2025 was AU$0.00. For the 2025 fiscal year, AU:ENP's free cash flow was decreased by AU$ and operating cash flow was AU$0.00. See a summary of the company’s cash flow.
Ratios
TTM
Jun 26Aug 24Jun 23Jun 22
Liquidity Ratios
Current Ratio
 7.94 7.94 9.08 3.87 2.67
Quick Ratio
 7.94 7.94 9.08 3.87 2.67
Cash Ratio
 5.46 5.46 4.33 2.93 0.96
Solvency Ratio
 -4.74 -4.74 -7.55 -3.35 -3.09
Operating Cash Flow Ratio
 -3.34 -3.34 -11.11 -3.27 -2.35
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 -2.63
Net Current Asset Value
AU$ 7.09MAU$ 7.09MAU$ 5.65MAU$ 5.25MAU$ 2.83M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.00 0.00 0.26
Debt-to-Equity Ratio
 0.00 0.00 0.00 0.00 0.37
Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.27
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.14 1.14 1.12 1.33 1.43
Debt Service Coverage Ratio
 -297.63 0.00 -486.20 -10.36 -2.73
Interest Coverage Ratio
 -416.71 0.00 -887.02 -9.19 -28.96
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.53
Interest Debt Per Share
 <0.01 0.00 <0.01 <0.01 0.02
Net Debt to EBITDA
 0.83 0.83 0.57 0.80 0.02
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%100.00%
EBIT Margin
0.00%0.00%0.00%0.00%-1099.16%
EBITDA Margin
0.00%0.00%0.00%0.00%-824.10%
Operating Profit Margin
0.00%0.00%0.00%0.00%-1550.61%
Pretax Profit Margin
0.00%0.00%0.00%0.00%-1152.70%
Net Profit Margin
0.00%0.00%0.00%0.00%-1152.70%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%-1152.70%
Net Income Per EBT
71.86%71.86%77.12%84.74%100.00%
EBT Per EBIT
100.12%100.12%102.74%145.96%74.34%
Return on Assets (ROA)
-58.07%-58.07%-80.03%-82.42%-121.24%
Return on Equity (ROE)
-63.60%-66.12%-89.41%-109.30%-172.77%
Return on Capital Employed (ROCE)
-91.90%-91.90%-112.84%-88.37%-230.20%
Return on Invested Capital (ROIC)
-66.04%-66.04%-87.03%-74.88%-168.27%
Return on Tangible Assets
-59.37%-59.37%-82.45%-86.69%-127.40%
Earnings Yield
-7.42%-9.70%-10.46%-32.76%-244.69%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 9.36
Payables Turnover
 0.03 0.13 0.25 <0.01 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.61
Asset Turnover
 0.00 0.00 0.00 0.00 0.11
Working Capital Turnover Ratio
 0.00 0.00 0.00 0.00 0.16
Cash Conversion Cycle
 -11.83K -2.89K -1.48K -68.42K 38.98
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 38.98
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 11.83K 2.89K 1.48K 68.42K 0.00
Operating Cycle
 0.00 0.00 0.00 0.00 38.98
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 >-0.01 >-0.01 -0.01 -0.05
Free Cash Flow Per Share
 >-0.01 >-0.01 >-0.01 -0.01 -0.05
CapEx Per Share
 <0.01 <0.01 <0.01 0.00 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.02 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -611.25 -611.25 -58.25 0.00 -1.01M
Capital Expenditure Coverage Ratio
 -611.25 -611.25 -58.25 0.00 -1.01M
Operating Cash Flow Coverage Ratio
 0.00 0.00 0.00 0.00 -2.63
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 0.00 -6.51
Free Cash Flow Yield
-5.36%-6.80%-15.50%-32.00%-138.15%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -16.96 -10.32 -9.49 -3.05 -0.41
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 0.00 4.71
Price-to-Book (P/B) Ratio
 8.91 6.82 8.55 3.34 0.71
Price-to-Free Cash Flow (P/FCF) Ratio
 -18.66 -14.72 -6.45 -3.12 -0.72
Price-to-Operating Cash Flow Ratio
 -19.26 -14.74 -6.56 -3.12 -0.72
Price-to-Earnings Growth (PEG) Ratio
 -0.17 0.50 0.14 0.04 0.01
Price-to-Fair Value
 8.91 6.82 8.55 3.34 0.71
Enterprise Value Multiple
 -8.62 -6.62 -9.10 -2.00 -0.55
Enterprise Value
 58.07M 44.62M 47.98M 13.38M 2.80M
EV to EBITDA
 -8.62 -6.62 -9.10 -2.00 -0.55
EV to Sales
 0.00 0.00 0.00 0.00 4.53
EV to Free Cash Flow
 -17.02 -13.08 -6.07 -2.23 -0.70
EV to Operating Cash Flow
 -17.05 -13.10 -6.17 -2.23 -0.70
Tangible Book Value Per Share
 <0.01 <0.01 <0.01 0.01 0.05
Shareholders’ Equity Per Share
 <0.01 <0.01 <0.01 0.01 0.05
Tax and Other Ratios
Effective Tax Rate
 0.28 0.28 0.23 0.15 0.00
Revenue Per Share
 0.00 0.00 0.00 0.00 <0.01
Net Income Per Share
 >-0.01 >-0.01 >-0.01 -0.01 -0.09
Tax Burden
 0.72 0.72 0.77 0.85 1.00
Interest Burden
 1.00 1.00 1.30 1.08 1.05
Research & Development to Revenue
 0.00 0.00 0.00 0.00 2.80
SG&A to Revenue
 0.00 0.00 0.00 0.00 10.36
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.70 0.70 1.46 0.98 0.69
Currency in AUD